| Novartis Pharma Schweiz AG - Kesimpta, Injektionslösung in Fertigspritze |
| 67757 | | 01 | | Kesimpta | | Injektionslösung in Fertigspritze | | L04AA52 | | Ofatumumab | | 01.02.2021 | | |
|
| Composition |
| ofatumumabum 20 mg, argininum, natrii acetas trihydricus, natrii chloridum, polysorbatum 80, dinatrii edetas, acidum hydrochloridum 25 per centum, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.92 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | Active Agent | Dose |
|---|
| Ofatumumabum | 20mg / 0.4ml |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum | 25 | | Arginine | | | Dinatrii Edetas | | | Sodium Acetate Trihydrate | | | Sodium Chloride | | | Per Centum | | | Polysorbatum 80 | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
